tmtpro 16plex reagent set (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
90
Structured Review
Thermo Fisher
tmtpro 16plex reagent set
Tmtpro 16plex Reagent Set, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tmtpro+16plex+set+lot%3Axc345162/tmt+reagent/pm38415587-68-5-9
Average 90 stars, based on 1 article reviews
Tmtpro 16plex Reagent Set, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tmtpro+16plex+set+lot%3Axc345162/tmt+reagent/pm38415587-68-5-9
Average 90 stars, based on 1 article reviews
tmtpro 16plex reagent set - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Sex-Specific Markers of Neuroinflammation and Neurodegeneration in the Spinal Cord Proteome of the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis. Article Snippet: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that has no cure.. The underlying mechanistic details of sex differences in the ALS spinal cord, the site of disease onset, are not understood to an extent that could guide novel drug development.. To address this, the spinal cords of 120-day-old wild-type (WT) and SOD1G93A (familial mouse model of ALS with mutant superoxide dismutase 1) mice were subjected to untargeted, quantitative proteomics using tandem mass tag acquisition on high-resolution mass spectrometric instrumentation. Labeling:Article Title: Sex-Dependent Changes to the Intestinal and Hepatic Abundance of Drug Transporters and Metabolizing Enzymes in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis. Article Snippet: Amyotrophic lateral sclerosis (ALS) is characterized by death and dysfunction of motor neurons that result in a rapidly progressing loss of motor function.. While there are some data on alterations at the blood−brain barrier (BBB) in ALS and their potential impact on CNS trafficking of drugs, little is reported on the impact of this disease on the expression of drug-handling proteins in the small intestine and liver.. This may impact the dosing of the many medicines that individuals with ALS are prescribed. |